// App-Quantinova.ai

P922 : HEALTH-RELATED QUALITY OF LIFE WITH TECLISTAMAB, A B-CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA FROM MAJESTEC-1

Researchers

Presenter

  • Rakesh Popat

Principal Investigators

  • Saad Z Usmani

  • Alfred Garfall

  • Maria-Victoria Mateos

  • Jess F San-Miguel

  • Albert Oriol

  • Ajay K Nooka

  • Laura Rosinol

  • Ajai Chari

  • Lionel Karlin

  • Amrita Krishnan

  • Nizar Bahlis

  • Thomas Martin

  • Britta Besemer

  • Joaqun Martnez-Lpez

  • Michel Delforge

  • John Fastenau

  • Katharine S Gries

  • Niels WCJ van de Donk

Medical Centers

  • Abramson Cancer Center, Perelman School of Medicine, University

  • University of Tubingen, Tubingen, Germany

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Mount Sinai School of Medicine, New York, NY

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • University College London Hospitals NHS Trust, London, United Kingdom

  • Mount Sinai School of Medicine, New York, NY

  • Mount Sinai School of Medicine,New York,Vereinigte Staaten

  • Development, LLC,Raritan, NJ,États-unis

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Development,Raritan, NJ,Vereinigte Staaten

  • University of Tuebingen,Tuebingen,Deutschland

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • University of Tuebingen,Tuebingen,Германия

  • Hematology Biology, University Hospital Hotel Dieu, Nantes, France

  • City of Hope Cancer Center,Duarte,United States

  • Arnie Charbonneau Cancer Institute,University of Calgary,Calgary,Kanada

  • City of Hope Cancer Center,Duarte,United States

  • Universit

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Janssen Research &amp

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Arnie Charbonneau Cancer Institute, University of Calgary,Calgary, CA,Vereinigte Staaten

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Winship Cancer Institute, Emory University Hospital,Atlanta, GA,Vereinigte Staaten

  • Mount Sinai School of Medicine,New York, NY,Estados Unidos

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Jansse

  • University of Tuebingen,Tuebingen,Deutschland

  • University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • University of California, San Francisco, San Francisco, California, United States

  • University of Tuebingen,Tuebingen,Deutschland

  • University of Tubingen, Tubingen, Germany

  • Mount Sinai Icahn School of Medicine, New York, New York, United States

  • City of Hope Cancer Center,Duarte,United States

  • University of California, San Francisco, San Francisco, CA

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Development,Raritan,United States

  • Hospital Clinic, University of Barcelona, Barcelona, Spain

  • Hospital Clínic, IDIBAPS, University of Barcelona,Barcelona,España

  • Winship Cancer Institute of Emory University,Atlanta, GA,Vereinigte Staaten

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Levine Cancer Institute/Atrium Health,Charlotte,Verenigde Staten

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • University of California San Francisco,San Francisco,Verenigde Staten

  • University of Tubingen, Tubingen, Germany

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA,Pamplona,España

  • Arnie Charbonneau Cancer Institute,University of Calgary,Calgary,Kanada

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • Abramson Cancer Center and University of Pennsylvania,Philadelphia, PA,États-unis

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • University of California, San Francisco, CA

  • Winship Cancer Institute of Emory University, Atlanta, GA

  • Service -Hematologie Clinique, Centre Hospitalier Lyon Sud, Pierre Benite, France

  • Amsterdam University Medical Center, Vrije Unive

  • Hematology Clinic, University Hospital Hôtel-Dieu,Nantes,Francia

  • Clínica Universidad de Navarra, CIMA, CIBERO

  • University of California, San Francisco, San Francisco, CA

  • Arnie Charbonneau Cancer Institute,University of Calgary,Calgary,Kanada

  • Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam,Paesi Bassi

  • University of California, San Francisco, San Francisco, CA

  • Mount Sinai School of Medicine, New York, NY

  • Arnie Charbonneau Cancer Institute,University of Calgary,Calgary,Kanada

  • Development,Raritan,Estados Unidos

  • University of Tubingen, Tubingen, Germany

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Institut Catala dOncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain

  • Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC,Madrid,Espagne

  • City of Hope Comprehensive Cancer Center,Duarte, CA,États-unis

  • University College London Hospitals NHS Foundation Trust,London,Vereinigtes Königreich

  • CIC,University Hospital of Salamanca/IBSAL,Salamanca,Spagna

  • Hospital Clínic, IDIBAPS, University of Barcelona,Barcelona,España

  • Universitaire Ziekenhuizen Leuven, Leuven, Belgium

  • Levine Cancer Institute, Atrium Health, Charlotte, NC

  • Development,Raritan, NJ,Vereinigte Staaten

  • University of Tuebingen,Tuebingen,Deutschland

  • Winship Cancer Institute, Emory University,Atlanta,États-unis

  • Development,Raritan,Stati Uniti

Locations

  • United Kingdom

  • France

  • United States

  • Mexico

  • Spain

  • Venezuela

  • Canada

  • Mali

  • Germany

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 2AP

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multinational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A